WinstonWınston
Edgewell Personal Care Company logo

Edgewell Personal Care Company

EPC
43
Household & Personal Products · Consumer Defensive
Price
$29.66
+0.48 (+1.64%)
Market Cap
$1.37B
Winston Score
43
Winston is serious
Mixed quality — meaningful strengths and weaknesses.

Share count falling — buybacks

13.8% over 4y

The company has reduced its share count over this period, returning value to shareholders through buybacks.

Diluted shares outstanding: 55.2M (2021) → 47.6M (2025)

Edgewell Personal Care is a consumer goods company that makes everyday personal care products. Its brands include Schick and Wilkinson Sword razors, Banana Boat and Hawaiian Tropic sunscreen, Carefree and Stayfree feminine care products, and Playtex. The company sells mostly to regular consumers through grocery stores, pharmacies, and big-box retailers like Walmart and Target.

Edgewell makes money by selling these branded products directly to retailers, who then sell them to shoppers. It operates mainly in North America and Europe, with a market cap of around $0.8 billion, making it a relatively small player compared to rivals like Procter & Gamble and Energizer. Its brand portfolio gives it some shelf-space leverage, but thin operating margins of just 3% and a very low return on invested capital of 1.3% signal that competition is intense and pricing power is limited — the main ongoing risk for the business.

Winston Score History

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

-10.5% YoY

YoY Growth Rate

Revenue declining

EPS Growth

-138.3% YoY

YoY Growth Rate

Earnings declining

R&D Spend

$58M/ year

Flat (-1% vs prior year)

2.6% of revenue

In line with sector average (2%)

Steady R&D investment year-over-year

Insider Activity

10.4%ownership

Rising

Insiders increasing their stake — aligned with shareholders

Cash Position

Cash flow positive

$300M cash & investments

Quarterly Free Cash Flow

↑ Burn rate improving

Company generates more cash than it spends — no dilution risk from fundraising

Revenue declining

Edgewell Personal Care Company's revenue is actually shrinking. In a growth stock, that removes the core investment thesis. The low Winston Score here may be warranted — unless there's a turnaround story.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin
43.4%
Healthy — 43.4% gross margin
Operating Margin
8.9%
Modest — 8.9% operating margin
ROCE
1.7%
Weak — 1.7% return on capital

ROIC between 0% and 5%. They earn a few cents back per dollar invested in the business.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY
+3.5%
Slow sales growth (3.5% YoY)
EPS YoY
-33.3%
Earnings shrinking (-33.3% YoY)

Earnings per share down more than 10%. Either a bad year, or a real decline.

EPS Consistency
0/8 quarters
Earnings rarely grow — volatile business

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion
1706%
Turns 1706% of profit into real cash
FCF Margin
9.5%
Modest free cash flow (9.5%)

FCF margin between 0% and 10%. Some cash from sales, but not a lot.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity
0.88
Moderate — manageable debt (0.88)
Interest Cover
1.69x
Dangerous — barely covers interest (1.7x)

Interest coverage between 1 and 3. Profits cover interest, but with little room to spare.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)
92.7x
Expensive — P/E 92.7

P/E over 35. The market is pricing in heavy, sustained growth.

P/E vs Forward
+78.2
GROWING
Earnings expected to grow meaningfully — cheaper on forward P/E (92.7 → 14.5)

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Dividend Yield
2.18%
Moderate income — 2.18% yield

Standard yield zone for stable dividend payers. A meaningful piece of total return.

Dividend Growth
+0.0%
Dividend flat

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial